Found 4 matching trials
Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients
PHASE2To compare versus placebo the efficacy and safety of recombinant Bet v1, na...
Location
Pr Gabrielle PAULI
Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis
PHASE2The purpose of this study is to find out if rBet v1-FV works to relieve Sea...
Location
Allergopharma GmbH & Co. KG
Efficacy and Safety From a Recombinant Folding Variant of Bet v 1
PHASE3Efficacy and Safety from a recombinant folding variant of Bet v 1...
Location
Allergopharma GmbH & Co. KG
Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic Derivative
PHASE2This trial is performed for the immunological and histological evaluation o...
Location
Prof. Dr. med. Sabina Rak